Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MAMBO: Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania

NCT03728153 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03728153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03728153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MAMBO: Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
November 26, 2019
Completion date
January 6, 2021
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke, stroke, ischemic